Copyright
©The Author(s) 2019.
World J Gastroenterol. Aug 14, 2019; 25(30): 4172-4180
Published online Aug 14, 2019. doi: 10.3748/wjg.v25.i30.4172
Published online Aug 14, 2019. doi: 10.3748/wjg.v25.i30.4172
Figure 1 LAL activity reduction in the spectrum of NAFLD.
LAL: Lysosomal acid lipase; NAFLD: Non-alcoholic fatty liver disease; NASH: Non-alcoholic steatohepatitis; CESD: Cholesterol esters storage disease.
- Citation: Baratta F, Pastori D, Ferro D, Carluccio G, Tozzi G, Angelico F, Violi F, Del Ben M. Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease? World J Gastroenterol 2019; 25(30): 4172-4180
- URL: https://www.wjgnet.com/1007-9327/full/v25/i30/4172.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i30.4172